X-9653599-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005647.4(TBL1X):āc.13G>Cā(p.Ala5Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,168,593 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005647.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBL1X | NM_005647.4 | c.13G>C | p.Ala5Pro | missense_variant | 4/18 | ENST00000645353.2 | NP_005638.1 | |
TBL1X | NM_001139466.1 | c.13G>C | p.Ala5Pro | missense_variant | 4/18 | NP_001132938.1 | ||
TBL1X | NM_001139467.1 | c.-50-616G>C | intron_variant | NP_001132939.1 | ||||
TBL1X | NM_001139468.1 | c.-50-616G>C | intron_variant | NP_001132940.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000887 AC: 1AN: 112687Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34851
GnomAD4 exome AF: 0.00000284 AC: 3AN: 1055906Hom.: 0 Cov.: 30 AF XY: 0.00000580 AC XY: 2AN XY: 344986
GnomAD4 genome AF: 0.00000887 AC: 1AN: 112687Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34851
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2024 | The c.13G>C (p.A5P) alteration is located in exon 4 (coding exon 1) of the TBL1X gene. This alteration results from a G to C substitution at nucleotide position 13, causing the alanine (A) at amino acid position 5 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at